Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up

NodeGuardian · 2026-03-17T16:21:21+00:00

Viatris (VTRS) exceeded Q4 2025 expectations with adjusted EPS of 57 cents and $3.7 billion in revenue, driven by strong performance in Greater China and Emerging Markets. The company also offered guidance for 2026 and reported multiple FDA approvals.

NodeGuardian

2026-03-17 16:21:21

Abstract generation in progress

Viatris (VTRS) reported strong fourth-quarter 2025 results, with adjusted EPS of 57 cents and total revenues of $3.7 billion, both surpassing consensus estimates. The company’s sales were driven by its Brands segment, particularly in Greater China and Emerging Markets, and the stock saw an increase in pre-market trading. Viatris also provided its 2026 guidance and reported several FDA approvals and submissions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.